» Articles » PMID: 31417571

Psoriasis: Obesity and Fatty Acids

Overview
Journal Front Immunol
Date 2019 Aug 17
PMID 31417571
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is chronic inflammatory skin disease affecting skin, joints, cardiovascular system, brain, and metabolism. The pathogenesis of psoriasis is mediated by a complex interplay between the immune system, inflammatory mediators of different pathways, e.g., TNF-alpha and the IL-23/IL-17 pathways, psoriasis-associated susceptibility loci, autoantigens, and multiple environmental factors. Psoriasis is triggered by the combination of genetic and environmental factors. A novel environmental risk factor with rising importance is obesity. Several studies proved that obesity is an independent risk factor for the onset and severity of psoriasis. Due to the dramatic increase of obesity worldwide this minireview focuses on obesity as a major environmental risk factor for psoriasis and the mechanisms of obesity-mediated exacerbation of psoriasis.

Citing Articles

Association between body roundness index and psoriasis among US adults: a nationwide population-based study.

Bai G, Peng Y, Liu Q, Shao X, Zhan Y, Chen A Lipids Health Dis. 2024; 23(1):373.

PMID: 39538202 PMC: 11559072. DOI: 10.1186/s12944-024-02365-w.


Metabolic Syndrome in Psoriasis Patients-an Observational Study.

Dascalu R, Barbulescu A, Dinescu S, Bita C, Stoica L, Sandu R Curr Health Sci J. 2024; 50(2):215-222.

PMID: 39371054 PMC: 11447491. DOI: 10.12865/CHSJ.50.02.06.


Novel Fatty Acid Biomarkers in Psoriasis and the Role of Modifiable Factors: Results from the METHAP Clinical Study.

Sarandi E, Krueger-Krasagakis S, Tsoukalas D, Evangelou G, Sifaki M, Kyriakakis M Biomolecules. 2024; 14(9).

PMID: 39334880 PMC: 11430636. DOI: 10.3390/biom14091114.


Role of Claudin- 3 as a biomarker of gut-skin axis integrity in patients with psoriasis.

Mahran A, Hosni A, Farag N, Elkhawaga A, Mageed A Arch Dermatol Res. 2024; 316(7):476.

PMID: 39023797 DOI: 10.1007/s00403-024-03071-4.


The circadian syndrome is a better predictor for psoriasis than the metabolic syndrome via an explainable machine learning method - the NHANES survey during 2005-2006 and 2009-2014.

Gu Y, Ye X, Zhao W, He S, Zhang W, Zeng X Front Endocrinol (Lausanne). 2024; 15:1379130.

PMID: 38988999 PMC: 11233539. DOI: 10.3389/fendo.2024.1379130.


References
1.
Mayser P, Grimm H, Grimminger F . n-3 fatty acids in psoriasis. Br J Nutr. 2002; 87 Suppl 1:S77-82. DOI: 10.1079/bjn2001459. View

2.
Rucevic I, Perl A, Barisic-Drusko V, Adam-Perl M . The role of the low energy diet in psoriasis vulgaris treatment. Coll Antropol. 2003; 27 Suppl 1:41-8. View

3.
Lee E, Trepicchio W, Oestreicher J, Pittman D, Wang F, Chamian F . Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med. 2004; 199(1):125-30. PMC: 1887731. DOI: 10.1084/jem.20030451. View

4.
Bowcock A, Cookson W . The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet. 2004; 13 Spec No 1:R43-55. DOI: 10.1093/hmg/ddh094. View

5.
Schon M, Boehncke W . Psoriasis. N Engl J Med. 2005; 352(18):1899-912. DOI: 10.1056/NEJMra041320. View